• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down1.54% Nasdaq Down1.52%

    Vertex Pharmaceuticals Incorporated (VRTX)

    -NasdaqGS
    125.07 Down 3.87(3.00%) Apr 17, 4:00PM EDT
    |After Hours : 125.01 Down 0.06 (0.05%) Apr 17, 5:47PM EDT
    Add to Portfolio
    Analyst OpinionGet Analyst Opinion for:
    Recommendation Summary*
    Mean Recommendation (this week):2.2
    Mean Recommendation (last week):2.3
    Change:-0.1

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Price Target Summary
    Mean Target:133.63
    Median Target:130.50
    High Target:200.00
    Low Target:85.00
    No. of Brokers:24

    Data provided by Thomson/First Call

    Upgrades & Downgrades History
    DateResearch FirmActionFromTo
    Jan 29, 2015Maxim GroupDowngradeBuyHold
    Jan 29, 2015NeedhamDowngradeBuyHold
    Nov 6, 2014CRT CapitalInitiated Buy
    Jun 25, 2014H.C. WainwrightDowngradeBuyNeutral
    Jan 6, 2014UBSUpgradeNeutralBuy
    Oct 30, 2013Summer Street ResearchDowngradeBuyNeutral
    Aug 22, 2013OppenheimerInitiated Outperform
    Apr 19, 2013Canaccord GenuityUpgradeHoldBuy
    Apr 10, 2013Chardan Capital MarketsInitiated Buy
    Feb 7, 2013Robert W. BairdInitiated Outperform

    More Upgrades & Downgrades for VRTX

    Data provided by Briefing.com - Take a free trial
    Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

    Recommendation Trends
    Current MonthLast MonthTwo Months AgoThree Months Ago
    Strong Buy0888
    Buy0779
    Hold0131311
    Underperform0000
    Sell0000

    Data provided by Thomson/First Call


    Currency in USD.